Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. [electronic resource]
Producer: 20150904Description: 834-44 p. digitalISSN:- 1533-4406
- Adult
- Aged
- Carbolines -- adverse effects
- Disease Progression
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Hospitalization
- Humans
- Hypertension, Pulmonary -- drug therapy
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Natriuretic Peptide, Brain -- blood
- Peptide Fragments -- blood
- Phenylpropionates -- adverse effects
- Pyridazines -- adverse effects
- Risk Factors
- Tadalafil
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.